UK markets close in 2 hours 48 minutes

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
44.37+1.34 (+3.11%)
At close: 04:00PM EST
44.37 0.00 (0.00%)
Pre-market: 08:25AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
352,962
335,659
26,678
129,160
0
Operating expenses
Research development
252,220
212,615
193,382
143,183
74,460
Selling general and administrative
75,294
60,326
46,480
32,349
15,680
Total operating expenses
327,514
272,941
239,862
175,532
90,140
Operating income or loss
25,448
62,718
-213,184
-46,372
-90,140
Income before tax
30,388
71,959
-197,965
-36,240
-88,185
Income tax expense
823
823
-351
-
-
Income from continuing operations
29,565
71,136
-197,614
-36,240
-88,185
Net income
29,565
71,136
-197,614
-36,240
-88,185
Net income available to common shareholders
29,565
71,136
-197,614
-36,240
-88,185
Basic EPS
-
0.65
-2.07
-0.39
-5.89
Diluted EPS
-
0.63
-2.07
-0.39
-5.89
Basic average shares
-
108,974
95,608
92,622
14,964
Diluted average shares
-
112,703
95,608
92,622
14,964
EBITDA
-
71,249
-205,193
-38,957
-87,058